Pet pharmaceuticals usher in an absorption revolution: Oral dissolving film technology breaks the shackles of traditional dosage forms

Pet Pharmaceuticals Usher in an Absorption Revolution: Oral Dissolving Film Technology Breaks the Shackles of Traditional Dosage Forms

Against the backdrop of the rapid development of the pet economy, the industry is facing a crucial opportunity for technological upgrading. While the current market is investing significant efforts in product design innovation—with many enterprises still caught in fierce competition over packaging designs, and even debating whether nutritional tablets should be round or square—a scientific breakthrough in "absorption efficiency" is triggering deeper reflections. The limitations of traditional dosage forms in dose design and bioavailability mean that most active ingredients struggle to exert their full effects. Wuhan Jinglong Biotechnology Co., Ltd.'s innovative exploration has provided a new solution for pet nutrient absorption: a completely different absorption pathway, namely absorption through the oral mucosa, rather than the traditional gastrointestinal absorption pathway. 

Practical Challenges of Traditional Dosage Forms: Objective Limitations in Absorption Efficiency

Absorption rate is affected by various factors, including drug dosage form, drug properties, administration method, and the pet's physiological state. According to relevant literature, the absorption rate of traditional tablets and capsules is very low, while that of oral dissolving films reaches 98%. The unique physiological characteristics of pets pose natural challenges to drug absorption:

A. The short intestinal tract (less than 1.2 meters) causes nutrients to be excreted before they can be absorbed; 

B. The strongly acidic gastric juice (pH 1-3), strongly alkaline bile (pH 10-12), and various digestive enzymes completely destroy nutrients; 

C. The habit of rapid eating and swallowing (in less than 10 seconds) together form a natural "drug blockade." 

What's more severe is that the absorption rate of the same dosage form can vary by up to 300% among pets of different breeds and ages. Golden Retrievers, with intestines 30% longer than Chihuahuas, have nearly double the absorption efficiency for tablets; while stressed kittens have a gastric emptying rate 40% faster than when they are calm. These individual differences make it a mystery—like the "vast stars and oceans"—how much nutrition one's own pet should actually be supplemented with, and how much of the ingested nutrition is actually absorbed. 

Nowadays, however, industry standards have directed most research and development resources toward the design of appearance and packaging. For example, the titanium alloy packaging box of some big brands' star products costs more than three times the cost of raw materials, while the actual amount that can be absorbed by pets is kept secret and avoided. 

Traditional tablets need to go through a long process of "chewing → decomposition by gastric acid → absorption in the small intestine → metabolism in the liver," with each link being a death trap for active ingredients. Take collagen supplements as an example: an international big brand claims that each tablet contains 1000mg of active ingredients, but less than 0.5% actually reaches the skin. Currently, the doses seen in pet food are just guesses, and the part that is actually absorbed into the bloodstream and takes effect may be less than a fraction. 

Biological Revolution of Oral Dissolving Films: Leap from Digestive Tract to Mucosa 

In the laboratory of Wuhan Jinglong Biotechnology Co., Ltd., researchers demonstrated the disruptive technology: "A transparent film the size of a postage stamp dissolves quickly upon contact with saliva, and nano-scale active molecules instantly enter the blood through tens of thousands of penetration points in the oral mucosa." This is equivalent to opening a second channel for the absorption of pet food. This innovative process, which integrates nano-dispersion technology, sustained-release formulations, and constant-temperature micro-level production process control, is rewriting the underlying logic of nutrient absorption. The permeability of the oral mucosa is 10 times that of the intestine, and it avoids degradation by pepsin, thus better exerting the effectiveness of the agent. 

Traditional oral drugs rely on gastrointestinal absorption, which has to go through three barriers: erosion by gastric acid and bile, enzymatic degradation, and the first-pass effect, resulting in a bioavailability generally lower than 20%. In contrast, oral dissolving film technology, by reshaping the drug delivery path, achieves a high-bioavailability shift from "destruction in the digestive tract" to "precise absorption through the mucosa." 

Oral dissolving films use the oral mucosa as the portal for drug penetration. Its stratum corneum is only 10-20μm thick (intestinal epithelial cells are 30-40μm), and it is rich in P-glycoprotein transporters. When the film comes into contact with saliva, the 0.08mm-thick nanofiber matrix disintegrates within 30 seconds, releasing drug molecules and nutrients that enter the bloodstream through the paracellular pathway. Experiments have proven that this technology breaks through three major bottlenecks of traditional dosage forms: 

1. Bypasses destruction by gastric acid (pH 1-3 environment); 

2. Avoids the hepatic first-pass effect (drugs do not need to go through portal circulation); 

3. Reduces loss due to intestinal enzymatic hydrolysis (shortens the absorption path). 

Industry Awakening: Transformation from "Selling Products" to "Creating Pathways" 

In the United States, the world's largest pet market, oral dissolving films are eroding the share of traditional dosage forms at an annual rate of 28%. Giants such as Pfizer and Elanco have quietly laid out their plans, but the uniqueness of the Chinese market is nurturing greater opportunities. 95% of domestic pet drug and nutritional product enterprises still use the tableting process from 200 years ago. Therefore, oral dissolving films, as a new dosage form empowering the pet industry, are definitely a cognitive gap market with a value of hundreds of billions. Almost all products on the market can be redeveloped based on oral dissolving films. 

It is worth noting that there is a chaotic phenomenon in the current industry of "emphasizing packaging over core content." In the "internet-famous supplements" that are popular on a certain e-commerce platform, the packaging cost accounts for 85% of the total product price. Some brands even launch diamond-encrusted embossed gift boxes, whose cost exceeds 10 times that of the raw materials. Behind this "visual premium" is a serious distortion of industry value standards. A survey by a third-party testing agency on 30 best-selling pet health products shows that 70% of the products have an actual bioavailability lower than 30% of the declared value, but marketing phrases such as "patented technology" and "quantum absorption" on the packaging are still prevalent. 

What's more serious is that the existing standard system still has structural loopholes. The current industry-standard "Technical Specifications for Inspection and Evaluation of Health Food" only requires the labeling of ingredient content, but does not mandate the disclosure of actual absorption rate data. An imported brand's fish oil gummies claim to contain 1000IU of vitamin D3 per piece, but third-party laboratory tests found that its liposome embedding technology results in an actual absorption rate of less than 30% of the labeled value. This information asymmetry directly leads consumers into a "paradox of choice": the more luxurious the packaging of a product, the higher the degree of deviation between its actual efficacy and price. It is imperative to establish a mandatory absorption rate disclosure system to return technological content to the core of value. 

New Era: Technological Breakthrough from Laboratory to Production Line 

Jinglong Biotechnology has invested millions to build a 100,000-class clean workshop, which has achieved fully automatic production of 200,000 pieces per day. The rapid-release film technology developed in collaboration with the Institute of Pharmaceutical Research of Union Hospital enables type II collagen to be quickly released and absorbed in dogs. As industry observers have said: "Whoever can take the lead in breaking through the absorption barrier will hold the future voice in pet medical care." 

The leap from "being able to eat" to "absorbing well," though seemingly simple, is actually a major breakthrough in the field of biomedicine. What we should produce is not industrial products that meet quality inspection standards, but keys to reshaping the quality of life. The improvement of absorption efficiency is not a simple technological iteration, but a redefinition of the quality of life of pets. With the continuous breakthroughs in biotechnology, we have reason to look forward to a new era of pet health centered on scientific absorption. 

 Jinglong Oral Dissolving Films, Easy Feeding, Happy Pet Raising